Normal height and novel mutations in growth hormone deficiency adults with pituitary stalk interruption syndrome

Neuro Endocrinol Lett. 2019 Dec;40(7-8):299-304.

Abstract

Objective: Pituitary stalk interruption syndrome (PSIS) is a rare congenital disease which results in hypopituitarism. Patients with PSIS often exhibit short stature due to their deficiency of growth hormone (GH).

Case presentation: Here, we present two rare cases of adults males with PSIS, in which the patients were of normal height and did not take any GH supplements. Sterility and multiple hormone deficiencies including GH were seen in both of them. Through whole exome sequencing of their DNA, we found novel mutations they shared, three in MUC4 (c.7815G>T, c.3548C>T, c.3399C>G) and one in NBPF10 (c.536C>A).

Conclusion: The present cases suggest that there are exceptions in GH deficient patients where a select few can attain normal heights without GH therapy. Genetic screening can be a predictor for prognoses of rare types of hypopituitarism.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Body Height / physiology*
  • Growth Disorders / metabolism*
  • Growth Disorders / physiopathology
  • Humans
  • Hypogonadism / drug therapy
  • Hypogonadism / metabolism*
  • Hypogonadism / physiopathology
  • Hypopituitarism / drug therapy
  • Hypopituitarism / metabolism*
  • Hypopituitarism / physiopathology
  • Hypothyroidism / drug therapy
  • Hypothyroidism / metabolism
  • Magnetic Resonance Imaging
  • Male
  • Mucin-4 / genetics
  • Pituitary Gland / abnormalities*
  • Pituitary Gland / diagnostic imaging

Substances

  • MUC4 protein, human
  • Mucin-4